Farnum Rhonda
SEC insider (Form 3/4/5 filer). CIK 0001898490. SVP, COMM & MEDICAL AFFAIRS at Theravance Biopharma, Inc. (TBPH). 32 reported Form 4/5 transactions since Sep 2024; latest on Sep 23, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Farnum Rhonda has filed insider reports for
- Theravance Biopharma, Inc. (TBPH): Officer, SVP, COMM & MEDICAL AFFAIRS
Farnum Rhonda
CIK: 0001898490
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Theravance Biopharma, Inc.
Discretionary Trading P&L
Holdings
Transaction History (32 total)
- Sep 23, 2026TBPH
Theravance Biopharma, Inc.
DispositionDirect89.1K shares- - Sep 23, 2026TBPH
Theravance Biopharma, Inc.
DispositionDirect124.4K shares- - Sep 15, 2026TBPH
Theravance Biopharma, Inc.
SaleDirect6.7K shares at avg. $17.03$113K - Sep 15, 2026TBPH
Theravance Biopharma, Inc.
SaleDirect3.3K shares at avg. $17.03$57K - Sep 15, 2026TBPH
Theravance Biopharma, Inc.
SaleDirect3.3K shares at avg. $17.03$57K - Aug 20, 2026TBPH
Theravance Biopharma, Inc.
Tax PaymentDirect5.7K shares at avg. $16.95$96K - Jun 15, 2026TBPH
Theravance Biopharma, Inc.
SaleDirect6.7K shares at avg. $16.39$109K - Jun 15, 2026TBPH
Theravance Biopharma, Inc.
SaleDirect3.3K shares at avg. $16.39$55K - Jun 15, 2026TBPH
Theravance Biopharma, Inc.
SaleDirect3.3K shares at avg. $16.38$55K - May 20, 2026TBPH
Theravance Biopharma, Inc.
Tax PaymentDirect5.7K shares at avg. $16.55$94K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Disposition | 89,062 | - | $0 | Direct |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Disposition | 124,414 | - | $0 | Direct |
| Sep 15, 2026 | TBPH Theravance Biopharma, Inc. | Sale | 6,657 | $17.03 | $113,397 | Direct |
| Sep 15, 2026 | TBPH Theravance Biopharma, Inc. | Sale | 3,329 | $17.03 | $56,707 | Direct |
| Sep 15, 2026 | TBPH Theravance Biopharma, Inc. | Sale | 3,328 | $17.03 | $56,690 | Direct |
| Aug 20, 2026 | TBPH Theravance Biopharma, Inc. | Tax Payment | 5,667 | $16.95 | $96,056 | Direct |
| Jun 15, 2026 | TBPH Theravance Biopharma, Inc. | Sale | 6,657 | $16.39 | $109,079 | Direct |
| Jun 15, 2026 | TBPH Theravance Biopharma, Inc. | Sale | 3,329 | $16.39 | $54,563 | Direct |
| Jun 15, 2026 | TBPH Theravance Biopharma, Inc. | Sale | 3,328 | $16.38 | $54,525 | Direct |
| May 20, 2026 | TBPH Theravance Biopharma, Inc. | Tax Payment | 5,678 | $16.55 | $93,971 | Direct |
1-10 of 32 transactions